ZUP1 and Miyoshi myopathy: To determine that reduced sensitivity to anti-MM drugs was not restricted to proteasome inhibitors, we recapitulated the impact of cluster formation and HS-5 stromal support by investigating the cytotoxic potency of the DUB inhibitor auranofin (AUR).